Business, energy, technology, markets and global industry news from Business News Today

dry eye disease

PharmaDeviceNews dry eye disease
A sterile ophthalmic vial in an eye exam setting highlights Saptalis Pharmaceuticals’ Cyclosporine Ophthalmic Emulsion 0.05% launch and growing generic dry eye treatment access. Representative image.
Pharma & Biotech

Can Saptalis Pharmaceuticals strengthen dry eye access with cyclosporine launch?

Find out how Saptalis Pharmaceuticals’ cyclosporine launch could reshape access, competition and generic dry eye treatment.

Read More
Medical Devices & Diagnostics

Why Bausch + Lomb’s ASCRS 2026 data slate matters for premium IOL competition and dry eye care

Find out why Bausch + Lomb’s ASCRS 2026 data package could reshape competition in cataract surgery, dry eye care, and ophthalmology platforms.

Read More